Merck (MRK) Operating Expenses (2009 - 2026)

Merck (MRK) has 18 years of Operating Expenses data on file, last reported at $19.8 billion in Q1 2026.

• Operating Expenses for Q1 2026 came in at $19.8 billion, up 105.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.1 billion (up 23.74% YoY), and the FY2025 annual result was $43.9 billion, down 0.65% from the prior year.
• Operating Expenses climbed to $19.8 billion in Q1 2026 per MRK's latest filing, from $13.0 billion in the prior quarter.
• Over five years, Operating Expenses peaked at $20.4 billion in Q2 2023 and troughed at $9.6 billion in Q1 2025.
• A 5-year average of $12.3 billion and a median of $10.8 billion in 2023 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses plunged 50.39% in 2024, then jumped 105.9% in 2026.
• A 5-year view of Operating Expenses shows it stood at $10.3 billion in 2022, then jumped by 61.64% to $16.7 billion in 2023, then slumped by 31.31% to $11.5 billion in 2024, then increased by 13.32% to $13.0 billion in 2025, then jumped by 52.7% to $19.8 billion in 2026.
• Business Quant data shows MRK's Operating Expenses at $19.8 billion in Q1 2026, $13.0 billion in Q4 2025, and $10.5 billion in Q3 2025.